The Role of DNA Repair in Genomic Instability of Multiple Myeloma.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 May 2022
Historique:
received: 12 04 2022
revised: 15 05 2022
accepted: 16 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

Multiple Myeloma (MM) is a B cell malignancy marked by genomic instability that arises both through pathogenesis and during disease progression. Despite recent advances in therapy, MM remains incurable. Recently, it has been reported that DNA repair can influence genomic changes and drug resistance in MM. The dysregulation of DNA repair function may provide an alternative explanation for genomic instability observed in MM cells and in cells derived from MM patients. This review provides an overview of DNA repair pathways with a special focus on their involvement in MM and discusses the role they play in MM progression and drug resistance. This review highlights how unrepaired DNA damage due to aberrant DNA repair response in MM exacerbates genomic instability and chromosomal abnormalities, enabling MM progression and drug resistance.

Identifiants

pubmed: 35628498
pii: ijms23105688
doi: 10.3390/ijms23105688
pmc: PMC9144728
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : grant number 154485
Pays : Canada
Organisme : Natural Sciences and Engineering Research Council
ID : RGPIN-2017-05752
Organisme : Cancer Research Society
ID : grant number 22019,

Références

J Med Genet. 2002 Dec;39(12):900-5
pubmed: 12471202
Leukemia. 2015 Nov;29(11):2119-25
pubmed: 26265183
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22953-22961
pubmed: 32868446
Cancer Treat Rev. 2016 Jan;42:3-9
pubmed: 26620820
Nat Rev Mol Cell Biol. 2016 Jun;17(6):337-49
pubmed: 27145721
Nucleic Acids Res. 2007;35(16):5545-55
pubmed: 17704129
J Clin Med. 2021 Apr 23;10(9):
pubmed: 33922721
Blood. 2009 Jul 30;114(5):1046-52
pubmed: 19436050
Front Immunol. 2020 May 29;11:1084
pubmed: 32547565
Front Oncol. 2014 Oct 30;4:289
pubmed: 25401086
Oncogene. 2016 Nov 10;35(45):5905-5915
pubmed: 27109101
Nat Rev Mol Cell Biol. 2014 Jul;15(7):465-81
pubmed: 24954209
DNA Repair (Amst). 2018 Aug;68:34-40
pubmed: 29929045
Leukemia. 2010 Jan;24(1):22-32
pubmed: 19907437
Mol Cancer Ther. 2016 Feb;15(2):241-50
pubmed: 26719576
J Exp Med. 1997 Feb 17;185(4):609-20
pubmed: 9034140
J Biol Chem. 2018 Jul 6;293(27):10536-10546
pubmed: 29530982
Clin Lymphoma Myeloma Leuk. 2020 Jul;20(7):e352-e367
pubmed: 32249195
Clin Lymphoma Myeloma. 2009 Oct;9(5):371-4
pubmed: 19858056
Cell. 2006 Jul 28;126(2):297-308
pubmed: 16873062
Mech Ageing Dev. 2008 Jul-Aug;129(7-8):391-407
pubmed: 18406444
Semin Oncol. 2013 Oct;40(5):537-48
pubmed: 24135398
PLoS One. 2015 Mar 19;10(3):e0121581
pubmed: 25790254
Redox Biol. 2019 Jul;25:101084
pubmed: 30612957
Front Biosci (Landmark Ed). 2017 Mar 1;22(9):1493-1522
pubmed: 28199214
Drugs. 2017 Apr;77(5):505-520
pubmed: 28205024
Annu Rev Biochem. 2005;74:681-710
pubmed: 15952900
Cell. 2006 Dec 29;127(7):1361-73
pubmed: 17190600
Leukemia. 2018 Jan;32(1):111-119
pubmed: 28588253
Curr Biol. 2017 Sep 25;27(18):R986-R988
pubmed: 28950089
Nature. 2005 Apr 14;434(7035):917-21
pubmed: 15829967
Blood. 1985 Aug;66(2):380-90
pubmed: 3926026
Mol Cancer Res. 2018 Mar;16(3):428-438
pubmed: 29222170
FEBS Lett. 2011 Sep 16;585(18):2853-60
pubmed: 21605559
J Biol Chem. 2005 Feb 11;280(6):4182-7
pubmed: 15550378
Clin Chem Lab Med. 2016 Jun 1;54(6):907-19
pubmed: 26509779
Mutat Res Rev Mutat Res. 2017 Jul;773:174-187
pubmed: 28927527
J Exp Med. 2009 Nov 23;206(12):2613-23
pubmed: 19887393
Carcinogenesis. 2004 Oct;25(10):1795-803
pubmed: 15142887
Immunol Res. 2012 Dec;54(1-3):233-46
pubmed: 22569912
Cell. 2006 Mar 10;124(5):943-55
pubmed: 16530042
PLoS One. 2013;8(2):e55493
pubmed: 23405159
Nature. 2011 Feb 3;470(7332):124-8
pubmed: 21293379
Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8076-81
pubmed: 9223317
Mol Cell. 2012 Aug 24;47(4):497-510
pubmed: 22920291
Cells. 2021 Aug 02;10(8):
pubmed: 34440730
Cancer Res. 2009 Dec 15;69(24):9367-75
pubmed: 19934314
DNA Repair (Amst). 2014 May;17:74-80
pubmed: 24613510
Blood. 2005 Jul 15;106(2):698-705
pubmed: 15802532
Oncogene. 2001 Sep 10;20(40):5611-22
pubmed: 11607813
DNA Repair (Amst). 2018 Nov;71:82-86
pubmed: 30174300
Nat Rev Mol Cell Biol. 2017 Aug;18(8):495-506
pubmed: 28512351
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2471-5
pubmed: 15699324
Blood Cancer J. 2020 Sep 28;10(9):94
pubmed: 32989217
Nat Rev Dis Primers. 2017 Jul 20;3:17046
pubmed: 28726797
Genes Environ. 2019 Jan 25;41:2
pubmed: 30700997
Int J Cancer. 2007 Mar 1;120(5):1036-45
pubmed: 17131345
Cancer Res. 2007 Aug 1;67(15):7395-405
pubmed: 17671210
Nature. 2005 Apr 14;434(7035):913-7
pubmed: 15829966
Expert Opin Biol Ther. 2013 Jun;13 Suppl 1:S69-82
pubmed: 23782016
Nature. 2009 Oct 22;461(7267):1071-8
pubmed: 19847258
Oncologist. 2020 Sep;25(9):e1406-e1413
pubmed: 32335971
Ther Clin Risk Manag. 2006 Sep;2(3):271-9
pubmed: 18360602
Front Genet. 2019 May 08;10:424
pubmed: 31139207
Cancers (Basel). 2020 Nov 24;12(12):
pubmed: 33255368
Clin Cancer Res. 2011 May 1;17(9):2919-33
pubmed: 21385930
Nature. 2000 Mar 30;404(6777):510-4
pubmed: 10761921
Cancers (Basel). 2020 Apr 23;12(4):
pubmed: 32340362
Exp Mol Pathol. 2008 Jun;84(3):256-61
pubmed: 18410922
Transl Stroke Res. 2019 Dec;10(6):664-671
pubmed: 30535792
Blood. 2011 Dec 8;118(24):6368-79
pubmed: 21917757
Blood. 2009 Mar 5;113(10):2290-7
pubmed: 19050310
Mutat Res. 2009 Jan 15;660(1-2):66-73
pubmed: 19028508
Genome Integr. 2012 Nov 27;3(1):9
pubmed: 23181949
Blood. 2003 Feb 15;101(4):1249-56
pubmed: 12393516
Microbiol Spectr. 2014 Dec;2(6):
pubmed: 26104458
Genes (Basel). 2013 Jul 25;4(3):375-87
pubmed: 24705210
Mod Pathol. 2006 Jul;19(7):914-21
pubmed: 16607377
Genes Dev. 2008 Jun 1;22(11):1478-89
pubmed: 18519640
Nat Rev Mol Cell Biol. 2017 Oct;18(10):610-621
pubmed: 28676700
Oncotarget. 2014 May 15;5(9):2487-98
pubmed: 24809299
Cold Spring Harb Perspect Biol. 2013 Apr 01;5(4):a012583
pubmed: 23545420
Blood. 2012 Aug 2;120(5):1067-76
pubmed: 22498740
Cold Spring Harb Perspect Biol. 2013 May 01;5(5):a012757
pubmed: 23637284
Cancer. 1975 Sep;36(3):842-54
pubmed: 1182674
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3535-3542
pubmed: 32015124
Ann N Y Acad Sci. 2016 Jan;1364:32-51
pubmed: 27002787
Blood. 2003 Mar 15;101(6):2377-80
pubmed: 12424198
Leuk Res. 2011 Sep;35(9):1178-83
pubmed: 21435719
Mutat Res. 2018 May;809:81-87
pubmed: 28754468
Mol Cell. 2001 Dec;8(6):1160-1
pubmed: 11885597
DNA Repair (Amst). 2019 Jan;73:110-119
pubmed: 30497961
Blood. 2004 Nov 15;104(10):3318-25
pubmed: 15304391
PLoS Genet. 2020 Jun 26;16(6):e1008902
pubmed: 32589669
Chem Res Toxicol. 1995 Mar;8(2):316-20
pubmed: 7766817
J Clin Oncol. 2015 Nov 20;33(33):3911-20
pubmed: 26282654
Crit Rev Biochem Mol Biol. 2010 Feb;45(1):23-49
pubmed: 20039786
Exp Mol Med. 2020 Oct;52(10):1705-1714
pubmed: 33122806
Leuk Lymphoma. 2019 Jul;60(7):1803-1811
pubmed: 30633655
Nat Commun. 2018 Aug 22;9(1):3363
pubmed: 30135448
Epigenetics. 2006 Jul-Sep;1(3):138-45
pubmed: 17965616
Hum Mol Genet. 2007 Dec 15;16(24):3117-27
pubmed: 17901044
Blood. 2011 Jan 6;117(1):211-20
pubmed: 20974671
Cell Biosci. 2020 Mar 30;10:49
pubmed: 32257107
Curr Opin Allergy Clin Immunol. 2015 Feb;15(1):89-97
pubmed: 25486379
Trends Cancer. 2020 Oct;6(10):858-873
pubmed: 32487486
J Natl Cancer Inst. 2002 Mar 20;94(6):461-2; author reply 463
pubmed: 11904319
Chromosoma. 2012 Feb;121(1):1-20
pubmed: 22048164
Leukemia. 2018 Jul;32(7):1561-1566
pubmed: 29467487
Blood. 2003 Feb 15;101(4):1520-9
pubmed: 12393535
Cell Biosci. 2020 Mar 16;10:39
pubmed: 32190289
DNA Repair (Amst). 2013 Jul;12(7):529-34
pubmed: 23684799
Mol Cell Biol. 2014 Apr;34(8):1380-8
pubmed: 24469398
Palliat Care Soc Pract. 2019 Oct 9;13:1178224219868235
pubmed: 32215370
Curr Opin Hematol. 2012 Jul;19(4):292-8
pubmed: 22517589
Mutat Res. 2000 Aug 30;460(3-4):245-56
pubmed: 10946232
Science. 2010 Mar 12;327(5971):1345-50
pubmed: 20223979
J Mol Biol. 1992 Sep 5;227(1):54-71
pubmed: 1522601
Cell Res. 2008 Jan;18(1):99-113
pubmed: 18166982
Hemasphere. 2020 Apr 03;4(2):e350
pubmed: 32309787
Nat Rev Clin Oncol. 2010 Mar;7(3):153-62
pubmed: 20142816

Auteurs

Jana Yasser Hafez Ali (JYH)

Biophysics Department, Faculty of Science, Cairo University, Giza 12613, Egypt.
Department of Oncology, Faculty of Medicine and Dentistry, University of Alberta, 11560 University Avenue, Edmonton, AB T6G 1Z2, Canada.

Amira Mohammed Fitieh (AM)

Biophysics Department, Faculty of Science, Cairo University, Giza 12613, Egypt.
Department of Oncology, Faculty of Medicine and Dentistry, University of Alberta, 11560 University Avenue, Edmonton, AB T6G 1Z2, Canada.

Ismail Hassan Ismail (IH)

Biophysics Department, Faculty of Science, Cairo University, Giza 12613, Egypt.
Department of Oncology, Faculty of Medicine and Dentistry, University of Alberta, 11560 University Avenue, Edmonton, AB T6G 1Z2, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH